Technology News and Research

RSS

Novartis Pharma agrees to further extend maturity date of Emisphere Technologies' Convertible Promissory Note

Emisphere Technologies, Inc., a biopharmaceutical company that focuses on a unique and improved delivery of pharmaceutical compounds and nutritional supplements using its Eligen® Technology, today announced that Novartis Pharma AG has agreed to further extend the maturity date of Emisphere’s Convertible Promissory Note to May 26, 2010.

25 Feb 2010

Asymptomatic pancreatic cyst treatment: UCLA-Veterans Affairs research team develops evaluation tool

As a result of improved imaging technology, pancreatic cysts are increasingly diagnosed in asymptomatic individuals who undergo scans for other reasons. And while most of these cysts follow a benign course, a small but significant number are either malignant at the time of diagnosis or have the potential to develop into pancreatic cancer during a patient's lifetime.

25 Feb 2010

Adoption of new technologies can transform healthcare system

According to Julie Klapstein, CEO of leading health information network Availity, LLC, “Technology adoption by health care providers will be a key determinant in the speed with which our nation’s health care system is transformed, and the speed at which patients and providers benefit from better clinical outcomes.”

25 Feb 2010

Focal therapy for localized prostate cancer: US HIFU announces intention to fund multi-center trial

US HIFU, a world leader in minimally invasive high intensity focused ultrasound (HIFU) technologies and manufacturer of the Sonablate® 500 medical device, has announced its intention to fund a landmark multi-center trial to study focal therapy for localized prostate cancer. Mark Emberton, M.D., (FRCS-Urology), consultant urological surgeon and divisional clinical director of cancer services at University College London Hospital (UCLH), along with Hashim Uddin Ahmed, MRC clinical research fellow, will lead the trial.

25 Feb 2010

JBG to develop new facility for cancer research

The JBG Companies has been chosen by the General Services Administration to build and own a new facility to house the nation's premier center for cancer research, the National Cancer Institute (NCI) in Montgomery County, Maryland.

25 Feb 2010

SeqWright deploys Isilon scale-out NAS storage solution for next-generation genomic sequencing services

Isilon® Systems today announced that SeqWright has deployed Isilon scale-out NAS as an end-to-end storage solution for its full range of next-generation genomic sequencing services. By combining Isilon's X-Series, NL-Series and Backup Accelerator, SeqWright has created a comprehensive solution for every stage of its DNA sequencing workflow – from primary storage, to nearline archival, to tape backup – accelerating time-to-results without requiring full-time storage administration.

25 Feb 2010

Brain implant helps scientists in determining link between brainwave patterns and attention

A paralyzed patient implanted with a brain-computer interface device has allowed scientists to determine the relationship between brain waves and attention.

25 Feb 2010

MicroTransponder awarded $2.6M NINDS SBIR FastTrack U44 grant, announces $7M Series B funding

MicroTransponder, Inc., a privately-held medical device company, has just announced a $7 Million Series B round of funding. MicroTransponder is developing a wireless neurostimulation platform for the treatment of chronic pain and other neurological indications.

25 Feb 2010

Identification of gaps in accessing stroke centers cuts down the deadly toll of stroke

When stroke strikes, choking off blood supply to the brain, every minute counts: Nearly 2 million neurons die each minute a stroke is left untreated, making it a race to recognize symptoms so that lifesaving "clot-busting" drugs can be administered.

25 Feb 2010

Eclipsys, Microsoft sign health information technology alliance

Eclipsys Corp.® and Microsoft Corp. today announced they have signed an alliance agreement to deliver the choice and flexibility that hospitals need and want to improve health information technology (HIT) efficiencies. Breaking with the tradition of closed, proprietary systems, the two companies will offer the market tightly integrated health IT solutions designed to make it easy for physicians, nurses and hospital administrators to gain insights from data aggregated from multiple clinical and financial systems across the hospital.

25 Feb 2010

Mariner to present HAI controlling dashboard at 2010 Microsoft Health User Group Exchange

Mariner, an industry-leading business intelligence, performance management and analytics solutions provider, will present an exciting new data-driven dashboard at the Microsoft Health User Group Exchange 2010 taking place during HIMSS10 at the Georgia World Conference Center in Atlanta, Georgia, February 28th. Designed to help the medical center’s infection control practitioner’s control HAIs, the Dashboard has been the subject of recent POC activity at Wake Forest University Baptist Medical Center (WFUBMC).

25 Feb 2010

New data shows Valortim antibody enhances human T cell response to B. anthracis

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that new data from the Company's Valortim® anthrax anti-toxin program were presented at the 8th Annual ASM Biodefense and Emerging Diseases Research Meeting, held in Baltimore, Maryland, February 21-24, 2010.

25 Feb 2010

EpiCept provides business update and fourth-quarter financial highlights

EpiCept Corporation today announced operating and financial results for the fourth quarter and year ended December 31, 2009, and provided an update on Ceplene® and several of the Company’s key product candidates.

25 Feb 2010

FDA, NIH initiative: From scientific breakthrough to the availability of new medical therapies for patients

The U.S. Food and Drug Administration and the National Institutes of Health today unveiled an initiative designed to accelerate the process from scientific breakthrough to the availability of new, innovative medical therapies for patients.

25 Feb 2010

BIDHC selects MedAptus Professional Intelligent Charge Capture technology

MedAptus(R), the market leader for charge capture technologies, today announced that Needham-based Beth Israel Deaconess HealthCare (BIDHC) has selected the company's Professional Intelligent Charge Capture technology for its hospitalist group. BIDHC, a network of primary care physicians, will roll-out the web-based version of MedAptus' Inpatient Edition for the timely and compliant capture of inpatient charges originating at three area hospitals.

25 Feb 2010

Deciphering babies' cries: Hope for new parents

Baby monitors of the future could translate infant cries, so that parents will know for certain whether their child is sleepy, hungry, needing a change, or in pain. Japanese scientists report details of a statistical computer program that can analyze a baby's crying in the International Journal of Biometrics.

25 Feb 2010

Virginia Life Science Investments completes recapitalization and management restructuring of Cupron

Virginia Life Science Investments, LLC and other investors have completed a recapitalization and management restructuring of Cupron, Inc., a Delaware corporation established in 2001, with principal offices in Modi’in, Israel. The transaction provides significant new capital to support the continued growth and development of Cupron Inc.; as well as the formation and initial capitalization of an independent new entity, Cupron Medical Inc., a Delaware corporation with principal offices in Richmond, VA.

25 Feb 2010

Genetic Disorder Tracker introduced by Guidepoint Global

Guidepoint Global, LLC, a leading primary research firm, today announced the launch of their Genetic Disorder Tracker, a monthly longitudinal data release that captures commercial trends, on a worldwide basis, associated with the treatment of eight rare genetic disorders: Gaucher's disease, Fabry's disease, PKU, MPS I (Hurler Syndrome), MPS II (Hunter Syndrome), MPS VI (Maroteaux-Lamy Syndrome), Niemann-Pick disease and Pompe disease.

25 Feb 2010

Zcube joins Mission Bay Capital Fund with $1M investment

Mission Bay Capital, LLC, has added a new limited partner to its first venture fund, bolstering the fund's ability to invest in promising bioscience companies emerging from the University of California.

25 Feb 2010

FDA may set patient safety regulations for health IT

The Huffington Post Investigative Fund: "In the past two years, the agency has received reports of six patient deaths and several dozen injuries linked to malfunctions in the systems, Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health, said in testimony prepared for a government hearing on Thursday. ... The FDA has been studying the issue for several years. Its latest concerns are surfacing as the government ramps up an ambitious plan to spend as much as $27 billion in stimulus money helping doctors and hospitals across the country purchase electronic medical records systems that rely on digital software rather than paper medical charts."

25 Feb 2010

Technology News and Research

Novartis Pharma agrees to further extend maturity date of Emisphere Technologies' Convertible Promissory Note

Asymptomatic pancreatic cyst treatment: UCLA-Veterans Affairs research team develops evaluation tool

Adoption of new technologies can transform healthcare system

Focal therapy for localized prostate cancer: US HIFU announces intention to fund multi-center trial

JBG to develop new facility for cancer research

SeqWright deploys Isilon scale-out NAS storage solution for next-generation genomic sequencing services

Brain implant helps scientists in determining link between brainwave patterns and attention

MicroTransponder awarded $2.6M NINDS SBIR FastTrack U44 grant, announces $7M Series B funding

Identification of gaps in accessing stroke centers cuts down the deadly toll of stroke

Eclipsys, Microsoft sign health information technology alliance

Mariner to present HAI controlling dashboard at 2010 Microsoft Health User Group Exchange

New data shows Valortim antibody enhances human T cell response to B. anthracis

EpiCept provides business update and fourth-quarter financial highlights

FDA, NIH initiative: From scientific breakthrough to the availability of new medical therapies for patients

BIDHC selects MedAptus Professional Intelligent Charge Capture technology

Deciphering babies' cries: Hope for new parents

Virginia Life Science Investments completes recapitalization and management restructuring of Cupron

Genetic Disorder Tracker introduced by Guidepoint Global

Zcube joins Mission Bay Capital Fund with $1M investment

FDA may set patient safety regulations for health IT

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News